Cargando…
The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer
BACKGROUND: Several classification systems are available to assess pathological response to neoadjuvant chemotherapy in breast cancer, but reliable biomarkers to predict the efficiency of primary systemic therapy (PST) are still missing. Deregulation of gap junction channel forming connexins (Cx) ha...
Autores principales: | Teleki, Ivett, Krenacs, Tibor, Szasz, Marcell A, Kulka, Janina, Wichmann, Barna, Leo, Cornelia, Papassotiropoulos, Barbel, Riemenschnitter, Cosima, Moch, Holger, Varga, Zsuzsanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583680/ https://www.ncbi.nlm.nih.gov/pubmed/23374644 http://dx.doi.org/10.1186/1471-2407-13-50 |
Ejemplares similares
-
Correlations of Differentially Expressed Gap Junction Connexins Cx26, Cx30, Cx32, Cx43 and Cx46 with Breast Cancer Progression and Prognosis
por: Teleki, Ivett, et al.
Publicado: (2014) -
Stability and prognostic value of Slug, Sox9 and Sox10 expression in breast cancers treated with neoadjuvant chemotherapy
por: Riemenschnitter, Cosima, et al.
Publicado: (2013) -
Connexin 43 Communication Channels in Follicular Dendritic Cell Development and in Follicular Lymphomas
por: Rajnai, Hajnalka, et al.
Publicado: (2015) -
Exploring Differential Connexin Expression across Melanocytic Tumor Progression Involving the Tumor Microenvironment
por: Kiszner, Gergo, et al.
Publicado: (2019) -
Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy
por: Zarotti, Cristina, et al.
Publicado: (2022)